Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $782.46 | 16 | 80.5% |
| Education | $189.98 | 2 | 19.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $457.80 | 8 | $0 (2019) |
| Teleflex LLC | $180.00 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $116.84 | 2 | $0 (2024) |
| Boston Scientific Corporation | $115.48 | 1 | $0 (2022) |
| UROGEN PHARMA, INC. | $51.16 | 2 | $0 (2024) |
| Cogentix Medical Inc. | $21.85 | 1 | $0 (2017) |
| Alnylam Pharmaceuticals Inc. | $15.35 | 1 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $13.96 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.30 | 3 | Janssen Biotech, Inc. ($86.14) |
| 2023 | $180.00 | 2 | Teleflex LLC ($180.00) |
| 2022 | $115.48 | 1 | Boston Scientific Corporation ($115.48) |
| 2021 | $15.35 | 1 | Alnylam Pharmaceuticals Inc. ($15.35) |
| 2019 | $194.43 | 4 | Astellas Pharma US Inc ($194.43) |
| 2018 | $92.21 | 2 | Astellas Pharma US Inc ($78.25) |
| 2017 | $237.67 | 5 | Astellas Pharma US Inc ($185.12) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $86.14 | General |
| Category: Oncology | ||||||
| 05/01/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/02/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Interventional Urology | ||||||
| 08/11/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Interventional Urology | ||||||
| 04/25/2022 | Boston Scientific Corporation | General - Vascular Intervention (Device) | Food and Beverage | In-kind items and services | $115.48 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 05/28/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Genetic Disease | ||||||
| 09/20/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $64.42 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 04/09/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: UROLOGY | ||||||
| 03/19/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2018 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Prostate Cancer | ||||||
| 10/12/2018 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $78.25 | General |
| 10/12/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $61.53 | General |
| 04/25/2017 | Cogentix Medical Inc. | Urgent PC (Device), Macroplastique, PrimeSight | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Urology | ||||||
| 03/28/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Oncology | ||||||
| 03/07/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 01/09/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
About Barry Kogan
Barry Kogan is a Pediatric Urology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174607923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Barry Kogan has received a total of $972.44 in payments from pharmaceutical and medical device companies, with $137.30 received in 2024. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($782.46).
Practice Information
- Specialty Pediatric Urology
- Other Specialties Urology
- Location Albany, NY
- Active Since 10/25/2006
- Last Updated 12/06/2011
- Taxonomy Code 2088P0231X
- Entity Type Individual
- NPI Number 1174607923
Products in Payments
- UROLIFT (Device) $180.00
- General - Vascular Intervention (Device) $115.48
- ERLEADA (Drug) $86.14
- XTANDI (Drug) $81.03
- JELMYTO (Drug) $51.16
- ZYTIGA (Drug) $30.70
- Xtandi (Drug) $23.60
- MYRBETRIQ (Drug) $23.41
- Urgent PC (Device) $21.85
- OXLUMO (Drug) $15.35
- ELIGARD (Drug) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.